This inventor holds 1 USPTO granted patent. Top assignee: Southwest Foundation for Biomedical Research. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Kathleen Born: Innovator in Atherosclerosis Research
Introduction
Kathleen Born is a notable inventor based in San Antonio, TX (US). She has made significant contributions to the field of biomedical research, particularly in the area of atherosclerosis. Her innovative work has led to the development of a unique polypeptide that has potential therapeutic applications.
Latest Patents
Kathleen Born holds a patent for a CETP inhibitor polypeptide and antibodies against the synthetic polypeptide. This polypeptide and its analogues inhibit cholesteryl ester transfer protein (CETP). The invention includes an anti-atherosclerosis composition that comprises an effective amount of the polypeptide and a pharmaceutically acceptable carrier. Additionally, an anti-atherosclerosis kit is provided, which includes separate sterile containers for the composition, a syringe, and a needle. The patent also describes an antibody that has specificity for the polypeptide, as well as methods for preventing and treating atherosclerosis in mammals.
Career Highlights
Kathleen Born is affiliated with the Southwest Foundation for Biomedical Research, where she continues her impactful work. Her research focuses on developing innovative solutions to combat atherosclerosis, a condition that poses significant health risks.
Collaborations
Some of her notable coworkers include Rampratap Kushwaha and Henry C McGill, Jr. Their collaborative efforts contribute to advancing research in the biomedical field.
Conclusion
Kathleen Born's contributions to atherosclerosis research through her innovative inventions highlight her role as a leading inventor in the biomedical community. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.